Aurinia Pharmaceuticals Inc. ( AUPH) - Stock Earnings
AUPH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 31.6 million USD | 73.5 million USD |
| 2025Q4 | 210.8 million USD | 77.1 million USD |
| 2026Q1 | 34.4 million USD | 77.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AUPH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -78.0 million USD | 175.5 million USD |
| 2024 | 5.8 million USD | 235.1 million USD |
| 2025 | 287.2 million USD | 283.1 million USD |
| 2026 Est. | — | — |
AUPH
Price: $16
52 week price:
Earnings Per Share: 2.16 USD
P/E Ratio: 7.07
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 2.2 million
Ebitda: -13.4 millionMarket Capitalization: 2.0 billion